TriSalus Life Sciences, Inc.TLSINASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+25.8%
5Y CAGR+241.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+25.8%/yr
Annual compound
5Y CAGR
+241.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
462.4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$50.17M+14.5%
2024$43.80M+8.0%
2023$40.55M+60.8%
2022$25.22M+48.2%
2021$17.02M+15584.0%
2020$108493.00-